| Pseudomonas aeruginosa infection in cystic fibrosis: pathophysiological mechanisms and therapeutic approaches H Lund-Palau, AR Turnbull, A Bush, E Bardin, L Cameron, O Soren, ... Expert review of respiratory medicine 10 (6), 685-697, 2016 | 160 | 2016 |
| Current and future therapies for Pseudomonas aeruginosa infection in patients with cystic fibrosis WD Smith, E Bardin, L Cameron, CL Edmondson, KV Farrant, I Martin, ... FEMS microbiology letters 364 (14), fnx121, 2017 | 126 | 2017 |
| Modulators of CFTR. Updates on clinical development and future directions E Bardin, A Pastor, M Semeraro, A Golec, K Hayes, B Chevalier, F Berhal, ... European journal of medicinal chemistry 213, 113195, 2021 | 46 | 2021 |
| Survival estimates in European cystic fibrosis patients and the impact of socioeconomic factors: a retrospective registry cohort study EF McKone, C Ariti, A Jackson, A Zolin, SB Carr, A Orenti, JG van Rens, ... European Respiratory Journal 58 (3), 2021 | 40 | 2021 |
| Metabolic Phenotyping and Strain Characterisation of Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients Using Rapid Evaporative Ionisation Mass … EE Bardin, SJS Cameron, A Perdones-Montero, K Hardiman, F Bolt, ... Scientific reports 8 (1), 10952, 2018 | 34 | 2018 |
| A novel application of nylon membranes for tributyltin determination in complex environmental samples by fluorescence spectroscopy and multivariate calibration MA Bravo, GM Escandar, AC Olivieri, E Bardin, LF Aguilar, W Quiroz Chemometrics and Intelligent Laboratory Systems 148, 77-84, 2015 | 7 | 2015 |
| Enhanced real-time mass spectrometry breath analysis for the diagnosis of COVID-19 C Roquencourt, H Salvator, E Bardin, E Lamy, E Farfour, E Naline, ... ERJ Open Research 9 (5), 2023 | 4 | 2023 |
| Volatile metabolites differentiate air–liquid interface cultures after infection with Staphylococcus aureus W Ahmed, E Bardin, MD Davis, I Sermet-Gaudelus, SG Delyle, SJ Fowler Analyst 148 (3), 618-627, 2023 | 4 | 2023 |
| “Il faut continuer à poser des questions” patient reported outcome measures in cystic fibrosis: An anthropological perspective R Coucke, A Chansard, V Bontemps, D Grenet, D Hubert, C Martin, ... Journal of Cystic Fibrosis 20 (6), e108-e113, 2021 | 4 | 2021 |
| CFTR modulators modify exhaled breath of children with cystic fibrosis within a week. E Bardin, N Hunzinger, E Lamy, B Zhou, N Remus, LLC Viala, P Devillier, ... European Respiratory Journal 62 (suppl 67), 2023 | 2 | 2023 |
| Analysis of Fingerprints by Desorption Electrospray Ionization Mass Spectrometry Imaging E Bardin, E Claude, Z Takats Waters Corp, 1-3, 2017 | 1 | 2017 |
| Therapeutics in cystic fibrosis: Clinical revolution and new challenges E Bardin, I Pranke, A Hinzpeter, I Sermet-Gaudelus Medecine Sciences: M/S 40 (3), 258-267, 2024 | | 2024 |
| Traitements de la mucoviscidose-Révolution clinique et nouveaux défis E Bardin, I Pranke, A Hinzpeter, I Sermet-Gaudelus médecine/sciences 40 (3), 258-267, 2024 | | 2024 |
| Lumacaftor/Ivacaftor Population Pharmacokinetics in Pediatric Patients with Cystic Fibrosis: A First Step Toward Personalized Therapy N Bouazza, S Urien, F Foissac, L Choupeaux, G Lui, ... Clinical Pharmacokinetics, 1-10, 2024 | | 2024 |
| Therapeutic drug monitoring of corticosteroids/β2-agonists in the hair of patients with asthma: an open-label feasibility study H Salvator, E Lamy, C Roquencourt, E Bardin, P Devillier, ... Frontiers in Pharmacology 14, 1339835, 2024 | | 2024 |
| A benchmark study of data normalisation methods for PTR-TOF-MS exhaled breath metabolomics C Roquencourt, E Lamy, E Bardin, P Devillier, S Grassin-Delyle Journal of Breath Research 18 (1), 016006, 2023 | | 2023 |
| Therapeutic drug monitoring of inhaled drugs in hair of patients with asthma: a proof-of-concept study H Salvator, S Delyle, C Roquencourt, F Lambinet, E Bardin, P Devillier, ... European Respiratory Journal 62 (suppl 67), 2023 | | 2023 |
| Diagnosis of COVID-19 with enhanced real-time mass spectrometry breath analysis C Roquencourt, H Salvator, E Bardin, E Lamy, E Farfour, N Emmanuel, ... European Respiratory Journal 62 (suppl 67), 2023 | | 2023 |
| Breath metabolomics to monitor the response to CFTR modulators in adults with cystic fibrosis E Bardin, H Salvator, C Roquencourt, I Sermet-Gaudelus, D Grenet, ... European Respiratory Journal 62 (suppl 67), 2023 | | 2023 |
| WS04. 04 CFTR modulator triple combination treatment modifies exhaled breath of children with cystic fibrosis within a week E Bardin, N Hunzinger, E Lamy, B Zhou, M Kelly, L Le Clainche, N Remus, ... Journal of Cystic Fibrosis 22, S8, 2023 | | 2023 |
